Loading...

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers

The antiproliferative effects of an antagonist of growth hormone-releasing hormone (GHRH) JV-1-38 were evaluated in nude mice bearing s.c. xenografts of LNCaP and MDA-PCa-2b human androgen-sensitive and DU-145 androgen-independent prostate cancers. In the androgen-sensitive models, JV-1-38 greatly p...

Full description

Saved in:
Bibliographic Details
Main Authors: Letsch, Markus, Schally, Andrew V., Busto, Rebeca, Bajo, Ana M., Varga, Jozsef L.
Format: Artigo
Language:Inglês
Published: The National Academy of Sciences 2003
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC298759/
https://ncbi.nlm.nih.gov/pubmed/12538852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0337496100
Tags: Add Tag
No Tags, Be the first to tag this record!